XORTX Therapeutics Reports Special Meeting Results
September 02, 2021 14:26 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Sept. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing...
XORTX Announces Grant of European Patent
September 01, 2021 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Sept. 01, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biotechnology company focused on developing therapeutics for the...
XORTX Announces New Clinical Advisory Board Member
August 31, 2021 09:11 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE:XRX) (OTCQB:XRTXF), a biotechnology company focused on developing innovative therapies to...
XORTX Therapeutics Calls Special Meeting of Shareholders
August 13, 2021 17:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, Aug. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing...
XORTX Therapeutics Strengthens Executive Team
July 14, 2021 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, July 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing...
Dr. Stephen Haworth Joins XORTX Management Team
June 30, 2021 07:00 ET
|
XORTX Therapeutics Inc.
● Dr. Haworth Appointed Chief Medical Officer ● CALGARY, Alberta, June 30, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical...
XORTX Welcomes Jaqueline Le Saux to Board of Directors
June 17, 2021 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, June 17, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biotechnology company focused on developing innovative therapies to...
XORTX Welcomes New Member to Board of Directors
May 13, 2021 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, May 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biotechnology company focused on developing innovative therapies to...
XORTX Announces Notice to Grant European Patent
April 06, 2021 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, April 06, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing therapeutics for...
XORTX to Present at “Zoom With LD MICRO”
March 16, 2021 07:00 ET
|
XORTX Therapeutics Inc.
CALGARY, Alberta, March 16, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative...